Document Detail


Recent developments in the prognostic use of myocardial perfusion imaging.
MedLine Citation:
PMID:  9429830     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Stress myocardial perfusion imaging has become a mainstay in the noninvasive assessment of patients with known or suspected coronary artery disease for several compelling reasons. Radionuclide myocardial perfusion imaging can be performed using a variety of stressors, including exercise, pharmacologic stress (including dipyridamole, adenosine, dobutamine, and arbutamine), or a combination of exercise and pharmacologic stress. The combination of exercise and pharmacologic stress allows an assessment of the patient's exercise tolerance, to be performed while adequately stressing him or her pharmacologically. Radiopharmaceutical choice has been expanded to include not only thallium-201 but also technetium-based imaging agents such as sestamibi and tetrofosmin. The use of technetium imaging agents has recently been enhanced by the ability to assess ventricular function using gated single-photon emission computed tomography (SPECT) imaging techniques. Finally, the ability to provide prognostic information in the same patients has led to incremental clinical use.
Authors:
M R Mansoor; G V Heller
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in cardiology     Volume:  12     ISSN:  0268-4705     ISO Abbreviation:  Curr. Opin. Cardiol.     Publication Date:  1997 Nov 
Date Detail:
Created Date:  1998-02-12     Completed Date:  1998-02-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8608087     Medline TA:  Curr Opin Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  571-80     Citation Subset:  IM    
Affiliation:
Division of Cardiology, Hartford Hospital, CT 06102-5037, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Trials as Topic
Coronary Disease / diagnosis,  physiopathology,  radionuclide imaging*
Exercise Test
Female
Heart / radionuclide imaging*
Humans
Male
Myocardial Infarction / diagnosis,  physiopathology,  radionuclide imaging*
Perfusion
Prognosis
Radionuclide Angiography
Sensitivity and Specificity
Technetium Tc 99m Sestamibi / diagnostic use
Tomography, Emission-Computed, Single-Photon*
Chemical
Reg. No./Substance:
109581-73-9/Technetium Tc 99m Sestamibi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Multimedia image display: a view to the future.
Next Document:  Perfusion and function assessment by nuclear cardiology techniques.